Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections.
Vicebio is tracked in the Tech.eu funding database. Based in London, UK; active in Healthtech. Acquired by Sanofi in 2025. Data as of 21 Aug 2026.
